A. Anton Torres - Aragon Health Research Institute, Miguel Servet University Hospital

基本信息

浏览量：0

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 14 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

N. Martínez-Jañez,M. Bellet Ezquerra, L. M. Manso Sanchez,F. Henao Carrasco,A. Anton Torres, S. Morales,P. Tolosa Ortega, V. L. Obadia Gil, T. Sampedro, R. Andrés Conejero, L. Calvo-Martinez, E. Galve-Calvo,

Breast Cancer Research and Treatment (2024)

引用0浏览0引用

First-line therapy with palbociclib in patients with advanced HR+/HER2− breast cancer: The real-life study PALBOSPAIN

N. Martínez-Jañez,M. Bellet Ezquerra, L. M. Manso Sanchez,F. Henao Carrasco,A. Anton Torres, S. Morales,P. Tolosa Ortega,V. L. Obadia Gil,T. Sampedro, R. Andrés Conejero, L. Calvo-Martinez, E. Galve-Calvo,

Breast Cancer Research and Treatmentpp.1-12, (2024)

引用0浏览0引用

First-line therapy with palbociclib in patients with advanced HR⁺/HER2^- breast cancer: The real-life study PALBOSPAIN

N. Martinez-Janez,M. Bellet Ezquerra,L. M. Manso Sanchez,F. Henao Carrasco,A. Anton Torres, S. Morales,P. Tolosa Ortega, V. L. Obadia Gil, T. Sampedro, R. Andres Conejero, L. Calvo-Martinez, E. Galve-Calvo,

BREAST CANCER RESEARCH AND TREATMENT (2024)

引用0浏览0引用

First-line therapy with palbociclib in patients with advanced HR+/HER2- breast cancer: The real-life study PALBOSPAIN

N Martínez-Jañez,M Bellet Ezquerra, L M Manso Sanchez,F Henao Carrasco,A Anton Torres, S Morales,P Tolosa Ortega,V L Obadia Gil,T Sampedro, R Andrés Conejero, L Calvo-Martinez, E Galve-Calvo,

Breast cancer research and treatment (2024)

引用0浏览0WOS引用

LBA19 Event-free survival (EFS) analysis of neoadjuvant taxane/carboplatin with or without atezolizumab followed by an adjuvant anthracycline regimen in high-risk triple negative breast cancer (TNBC): NeoTRIP Michelangelo randomized study

L. Gianni,C. Huang, D. Egle, B. Bermejo, C. Zamagni, M. Thill,A. Anton Torres, G. Bianchini, E. Sevillano Fernandez, S. Russo, E.M. Ciruelos, R. Greil,

Annals of Oncology (2023): S1258-S1259

引用0浏览0引用

134P Impact of pre-operative MammaPrint/BluePrint use for final treatment decisions in patients with stage II/IIIa HR+/HER2- early-stage breast cancer eligible for neoadjuvant chemotherapy: The DETERMIND study

S. Marin-Liebana, S. Morales,A. Anton Torres, V. Iranzo, A.L. Guerrero Zotano, J. Ponce, E. Adrover,P. Sanchez-Rovira,A. Perello Martorell,L. de la Cruz Merino,M. Ruiz Borrego, J.C. Toral,

ESMO Openno. 1 (2023): 101473-101473

引用0浏览0引用

203P Clinical effectiveness of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer (mBC) by ER expression level: Subgroup analysis from phase IIIb LUCY trial

K.A. Gelmon,P.A. Fasching, S. Delaloge,Y.H. Park, A.F. Eisen, H. Bourgeois, Z. Kemp, T. Jankowski, J. Sohn, S. Aksoy, C.V. Timcheva,T-W. Park-Simon,

ESMO Openno. 1 (2023): 101392-101392

引用0浏览0引用

234P Real-world treatment patterns and outcomes of patients receiving palbociclib plus endocrine therapy in Spain: Subgroup analysis based on age, sites and number of metastatic locations, menopausal status and dose received from PALBOSPAIN study

F. Moreno Anton, M. Bellet-Ezquerra,L.M. Manso Sanchez,F. Henao Carrasco,A. Anton Torres,S. Morales,P. Tolosa Ortega,V.L. Obadia Gil, T. Sampedro, R. Andrés Conejero, L. Calvo-Martinez, E. Galve-Calvo,

ESMO Openno. 1 (2023): 101422-101422

引用0浏览0引用

174P Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting: Phase IIIb LUCY final analysis

J. Balmana,P.A. Fasching, S. Delaloge,Y.H. Park, A. Eisen, H. Bourgeois, Z. Kemp, T. Jankowski,J. Sohn,S. Aksoy, C.V. Timcheva,T-W. Park-Simon,

Annals of Oncology（2022）

引用2浏览0引用

Lurbinectedin in patients with pretreated BRCA1/2-associated metastatic breast cancer: Results from a phase II basket study

Valentina Boni,Barbara Pistilli,Irene Braña,Geoffrey I. Shapiro,Jose Manuel Manuel Trigo Perez,Víctor Moreno, Daniel Castellano,Cristian Fernández,Carmen Kahatt,Vicente Alfaro,Mariano Siguero,Ali Zeaiter,

Journal of Clinical Oncologyno. 16_suppl (2022): 1092-1092

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn